Hany Massarany is Director of Accelerate Diagnostics, Inc. Currently has a direct ownership of 36,891 shares of AXDX, which is worth approximately $47,958. The most recent transaction as insider was on Jun 28, 2024, when has been sold 4,737 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.9K
52.07% 3M change
51.43% 12M change
Total Value Held $47,958

HANY MASSARANY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 28 2024
BUY
Exercise of conversion of derivative security
-
4,737 Added 11.38%
36,891 Common Stock
May 29 2024
BUY
Exercise of conversion of derivative security
-
7,894 Added 19.71%
32,154 Common Stock
Jan 23 2024
BUY
Open market or private purchase
-
16,666 Added 40.72%
24,260 Common Stock
May 31 2023
BUY
Exercise of conversion of derivative security
-
75,949 Added 50.0%
75,949 Common Stock

Also insider at

BDSX
BIODESIX INC Healthcare
HM

Hany Massarany

Director
Boulder, CO

Track Institutional and Insider Activities on AXDX

Follow Accelerate Diagnostics, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXDX shares.

Notify only if

Insider Trading

Get notified when an Accelerate Diagnostics, Inc insider buys or sells AXDX shares.

Notify only if

News

Receive news related to Accelerate Diagnostics, Inc

Track Activities on AXDX